The fibrin-specific plasminogen activator – which is already sold as Metalyse and TNKase for patients with suspected acute myocardial infarction – was being tested in phase 3 stroke trials ...
Correspondence to: Dr J M Wardlaw Division of Clinical Neurosciences, Western General Hospital, Crewe Rd, Edinburgh EH4 2XU UK; joanna.wardlawed.ac.uk ...